Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer
Detection Rate by Blue Laser Imaging (BLI) of Secondary or Early Squamous Head and Neck Cancer in Patients Undergoing Elective Percutaneous Endoscopic Gastrostomy (PEG)
Sponsor: Georg Dultz
A NA clinical study on Esophageal Cancer and Gastrostomy, this trial is ongoing. The trial is conducted by Georg Dultz and has accumulated 6 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Jun 2025 — Present [monthly]
Unknown NA
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Jun 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Aug 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Aug 2023 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Oct 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Sep 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Georg Dultz
For direct contact, visit the study record on ClinicalTrials.gov .